Experts
Experts include leading international venture capitalists, corporates, investors, international business executives & prestigious experts in their field, who will share their expertise in the various presentation sessions.
Oscar Arriaga Lasterra
Project Manager
Sociedad de Desarollo de Navarra (SODENA)
(Spain)
Lluis Ballell-Pages
Principal Scientist
GlaxoSmithKline
(Spain)
Siegfried Bialojan
Industry Leader Health Sciences Germany
Ernst & Young Germany
(Germany)
Jasper Bos
Director Merck Serono Ventures
Merck Serono Ventures
(Switzerland)
Carlos Sarobe Carricas
Project Manager
Sociedad de Desarollo de Navarra (SODENA)
(Spain)
Laia Crespo
Ysios Capital Partners SGECR, SA
(Spain)
Adrian Dawkes
Senior Director
PharmaVentures
(United Kingdom)
Ola Forsström-Olsson
CEO & Founder
Ludesi AB
(Sweden)
Maria Garcia Arellano
Projects staff assistant
Sociedad de Desarollo de Navarra (SODENA)
(Spain)
Constantino Gomez
CFA
Arcano Capital
(Spain)
Carlos Hidalgo Andres
Partner / Principal
Ernst &Young
(Spain)
Els Hubloux
Senior Investment Manager
Quest Management NV
(Belgium)
Sofia Ioannidou
Associate
Edmond de Rothschild Investment Partners
(France)
Marcel Kloosterman
DSM Venturing / Chemelot Ventures
(Netherlands)
Manuel Lopez-Figueroa
Bay City
(United States)
Raúl Martín-Ruiz
Investment Director
Ysios Capital Partners SGECR, SA
(Spain)
José Antonio Mesa
Investment Director
Caixa Capital Risc SGECR SA
(Spain)
Bruno Montanari
Investment manager
Credit Agricole Private Equity
(France)
Diana Medeiros Placido
Junior Associate
McKinsey & Company
(Spain)
Ricardo Pérez Merino
Managing Director
CLAVE CAPITAL
(Spain)
Juan J Pérez Villar
Partner
Biolty
(Spain)
Gordon Ryerson
Managing Director and Co-Founder
Crosstree Capital Partners, Inc.
(United States)
Julia Salaverria
Founding Partner
Ysios Capital Partners SGECR, SA
(Spain)
Josep Ll Sanfeliu
Founding Partner
Ysios Capital Partners SGECR, SA
(Spain)
Jens Sundbye
SunConsult ApS
(Denmark)
Christian Suojanen
Director – Life Sciences
Valor Management
(Switzerland)
Christiane Verhaegen
CEO
Unibioscreen
(Belgium)
Hartmut Voss
Scientific Director
dievini Hopp BioTech holding GmbH & Co. KG
(Germany)
Karen Wagner
Venture Partner
Ysios Capital Partners SGECR, SA
(Spain)
Mark Wilson
Director, SR One, GlaxoSmithKline
GlaxoSmithKline
(United Kingdom)
Werner Wolf
CEO and Founder
Bio Innovations
(Switzerland)